As of Friday close, DexCom Inc.’s (NASDAQ:DXCM) stock was down -$1.74, moving down -1.43 percent to $120.33. The average number of shares traded per day over the past five days has been 3,425,780 shares. 1 time new highs have been achieved over the past 5 days, with a -$12.05 fall in that time frame. In the last twenty days, the average volume was 3,063,880, while in the previous 50 days, it was 2,926,900.
Since last month, DXCM stock retreated -5.77%. Shares of the company fell to $119.89 on 08/04/23, the lowest level in the past month. A 52-week high of $139.55 was reached on 07/28/23 after having rallying from a 52-week low of $78.94. Since the beginning of this year, DXCM’s stock price has risen by 6.26% or $7.09, and marked a new high 21 times. However, the stock has declined by -13.77% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
DXCM stock investors should be aware that DexCom Inc. (DXCM) stock had its last reported insider trading activity 12 days ago on Jul 24. Pacelli Steven Robert, the EVP Managing Director Dexcom V of the company, disposed of 412 shares for $130.58 on Jul 24. It resulted in a $53,799 divestment by the insider. Pacelli Steven Robert sold 5,031 shares at an average price of $136.00 on Jul 14. The insider now owns 126,831 shares following the transaction. On Jul 10, EVP Operations Regan Barry J. sold 1,989 shares at $128.05 apiece. The transaction was valued at $254,691.
Valuation Metrics
Right now, DexCom Inc. (DXCM) has a P/E ratio of about 174.39. The stock’s beta is 1.09. Besides these, the trailing price-to-sales (P/S) ratio of 15.08, the price-to-book (PB) ratio of 22.16, and the price-to-cash flow ratio of 97.81 may also be considered.
Financial Health
In the three months ended June 29, DexCom Inc.’s quick ratio stood at 2.20, while its current ratio was 2.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 1.19, and the total debt-to-equity ratio was 1.55. On the profitability front, the trailing twelve-month gross margin is 64.90% percent. In the year ended June 29, EBITDA margin amounted to 18.80%, whereas operating margins totaled 14.80%. Based on annual data, DXCM earned $1.88 billion in gross profit and brought in $2.91 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 8.20%. Return on equity (ROE) for the past 12 months was 17.30%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. DXCM’s revenue rose 20.1% to $741.5 million during the quarter, while net income inched up to $871.3 million. While analysts expected DexCom Inc. to report $0.23 quarterly earnings, the actual figure was $0.34 per share, beating the consensus estimate by 47.80%. During the quarter, the company generated $171.8 million in EBITDA. The liabilities of DexCom Inc. were 4.72 billion at the end of its most recent quarter ended June 29, and its total debt was $3.37 billion. The value of shareholders’ equity is $387.87 million.
Technical Picture
This quick technical analysis looks at DexCom Inc.’s (DXCM) price momentum. With a historical volatility rate of 38.28%, the RSI 9-day stood at 31.49% on 04 August.
With respect to its five-day moving average, the current DexCom Inc. price is down by -9.10% percent or -$12.05. At present, DXCM shares trade -5.04% below its 20-day simple moving average and +8.74% percent above its 100-day simple moving average. However, the stock is currently trading approximately +4.01% above its SMA50 and +20.66% above its SMA200.
Stochastic coefficient K was 9.41% and Stochastic coefficient D was 8.54%, while ATR was 4.32. Given the Stochastic reading of 2.24% for the 14-day period, the RSI (14) reading has been calculated as 37.06%. As of today, the MACD Oscillator reading stands at -4.06, while the 14-day reading stands at -6.19.
Analyst Ratings
DexCom Inc. (DXCM) has been rated Buy by analysts. According to 0 brokerage firms, DXCM is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 4 analysts rate DexCom Inc. stock as buy, with 16 recommending it as overweight.
With a median target price of $150.00, the current consensus forecast for the stock is $131.00 – $175.00. Based on these forecasts, analysts predict DexCom Inc. (DXCM) will achieve an average price target of $150.32.
